Clinical trial
A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
NCT01483690 is registered in ClinicalTrials.gov with Therapeutic Advances in Childhood Leukemia Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
- Lead sponsor
- Therapeutic Advances in Childhood Leukemia Consortium
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- December 31, 2011
- Completion date
- July 31, 2015
- Enrollment
- 23 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, precursor b-cell lymphoblastic leukemia, precursor t-cell lymphoblastic leukemia